AR
Aavant Research
GLOW
252 tests · latest 11 May 2026
62%
NEA rating
#10 of 17 GLOW vendors
1 of 2 classifiable tests passed
natural 92% · customers 4.2★ (26)
NEA analysis · GLOW
Aavant Research GLOW is a mixed picture: purity reads 96.6% while fill comes in light at 90.1% of label. Expect batch to batch swings and confirm the lot before relying on the number.
Balanced — purity 98%+, dose ±20%methodology
Peptides
14 rated · tap to focus| # | Peptide | Rating | N |
|---|---|---|---|
| 1 | GLOWselected | 62% | 2 |
| 2 | KPV | 53% | 7 |
| 3 | Thymosin Alpha 1 | 48% | 24 |
| 4 | Melanotan II | 39% | 32 |
| 5 | SS 31 | 30% | 32 |
| 6 | IGF 1 LR3 | 19% | 27 |
| 7 | Epithalon | 18% | 5 |
| 8 | Kisspeptin 10 | 16% | 13 |
| 9 | Semaglutide | 10% | 26 |
| 10 | GHK Cu | 2% | 13 |
| 11 | Selank | 2% | 24 |
| 12 | Retatrutide | 0% | 8 |
| 13 | Cagrilintide | 0% | 15 |
| 14 | Semax | 0% | 24 |
Rating trend
GLOW rating from this vendor, after each test
Aavant Research GLOW test history
2 tests · 1 pass · 1 fail
| Date | Result | Purity | Dosage | Label |
|---|---|---|---|---|
| 11 May 2026 | Pass | 97.02%Identity Pass | -5.2%28.44 mg tested / 30 mg label | Batch GL202602sent by Public |
| 29 Apr 2026 | Fail | 96.1%Content Fail | -14.6%25.62 mg tested / 30 mg label | Batch GL202601sent by Public |
1-2 of 2